<DOC>
	<DOCNO>NCT00133458</DOCNO>
	<brief_summary>This study enroll 120 individual diagnose subarachnoid cysticercosis , disease cause invasion basal part brain parasite name Taenia solium . Subarachnoid cysticercosis usually treat albendazole one month kill parasite . This study determine two month albendazole ( ABZ ) therapy well one-month . The study last 3 year .</brief_summary>
	<brief_title>RCT ALB SA Cysticercosis</brief_title>
	<detailed_description>This randomize , double blind comparison two lengths albendazole thereapy subarachnoid cysticercosis . It enroll 120 individual , male female age 18 65 , diagnose subarachnoid cysticercosis , disease cause invasion basal part brain parasite name Taenia solium . Subarachnoid cysticercosis usually treat albendazole one month kill parasite . This study determine two month albendazole ( ABZ ) therapy well one-month . The study last 3 year .</detailed_description>
	<mesh_term>Cysticercosis</mesh_term>
	<mesh_term>Taeniasis</mesh_term>
	<mesh_term>Neurocysticercosis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>Male female individual 1865 year age diagnosis basal subarachnoid cysticercosis , base MRI confirm serological test . Willingness accomplish two week minimal hospitalization require . Female childbearing potential willing use adequate method contraception include implant , injectables , combine oral contraceptive , effective intrauterine device , sexual abstinence , vasectomized partner participate study . Patients normal laboratory value hemoglobin , platelet count , total white blood cell , glucose , creatinine , bilirubin , ALT , AST , electrolytes . Negative fecal exam Taenia egg . Previous therapy albendazole ( include patient receive singledose 400 mg ABZ intestinal parasite ) , praziquantel . Pulmonary tuberculosis evidence positive chest Xray positive sputum smear . Preexisting diagnosis diabetes Systemic disease NCC may affect therapy shortterm prognosis , include limited chronic renal failure , hepatic insufficiency , cardiac failure , steroiddependent immune disease . Identification systemic disease leave discretion Site PI . Patients unstable condition severe intracranial hypertension ( ICH ) . Definition severe ICH study would presence headache , nausea , vomit papilledema fundoscopic examination ( ) . Patients category consider entrance study treatment ICH ventricleperitoneal shunt . Patients CT finding compatible intracranial hypertension neurosurgical evaluation ( non study personal ) study entry . Pregnancy History hypersensitivity albendazole Concurrent treatment praziquantel , cimetidine teophylline . Chronic alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Albenza , Subarachnoid cysticercosis</keyword>
</DOC>